MMP14 and leukemia: To explore the clinical relevance, we co-cultured Kasumi-1 and Molm-13 leukemia cell lines with MSCs in vitro, and treated the co-cultures with either the specific MMP14 inhibitor NSC-405,020 [32]or Ara-C to evaluate the combinatorial effect.